References

Bioactive compounds as therapeutic modulators of metabolic syndrome: targeting inflammation and gut microbiota regulation

10.3389/fphys.2026.1766078 · 2026 · External reference

Polyphenols, food and pharma. Current knowledge and directions for future research

10.1016/j.bcp.2018.07.050 · 2018 · External reference

Dose-dependency of the glycemic response to polyphenol-rich sugarcane extract (PRSE)

10.3390/biologics3040016 · 2023 · External reference

Efficacy of dietary polyphenols from whole foods and purified food polyphenol extracts in optimizing Cardiometabolic health: a Meta-analysis of randomized controlled trials

10.1016/j.advnut.2023.01.002 · 2023 · External reference

Micronutrient supplementation to reduce cardiovascular risk

10.1016/j.jacc.2022.09.048 · 2022 · External reference

Bioaccessibility and bioavailability of diet polyphenols and their modulation of gut microbiota

10.3390/ijms24043813 · 2023 · External reference

A polyphenol rich sugarcane extract as a modulator for inflammation and neurological disorders

10.1016/j.phanu.2020.100187 · 2020 · External reference

From feed to fork: immunity, performance and quality of products from farm animals fed sugarcane products

10.3389/fanim.2024.1352961 · 2024 · External reference

Protective effects of sugarcane polyphenol against UV-B-induced photoaging in Balb/c mouse skin: antioxidant, anti-inflammatory, and anti-glycosylation effects

10.1111/1750-3841.17045 · 2024 · External reference

The relevance of dietary polyphenols in cardiovascular protection

10.2174/1381612823666170329144307 · 2017 · External reference

DELTA2 guidance on choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial

10.1136/bmj.k3750 · 2018 · External reference

New guidance to improve sample size calculations for trials: eliciting the target difference

10.1186/s13063-018-2894-y · 2018 · External reference

Breaking new frontiers: assessment and re-evaluation of clinical trial design for nutraceuticals

10.3389/fnut.2022.958753 · 2022 · External reference

A randomized crossover trial on the effect of plant-based compared with animal-based meat on trimethylamine-N-oxide and cardiovascular disease risk factors in generally healthy adults: study with appetizing Plantfood-meat eating alternative trial (SWAP-MEAT)

10.1093/ajcn/nqaa203 · 2020 · External reference

Wash-in and washout effects: mitigating bias in short term dietary and other trials

10.1136/bmj-2024-082963 · 2025 · External reference

Behavioral carry-over effect and power consideration in crossover trials

10.1093/biomtc/ujae023 · 2024 · External reference

KEGG for taxonomy-based analysis of pathways and genomes

10.1093/nar/gkac963 · 2023 · External reference

Unresolved reference

1998 · External reference

Development and validation of brief measures of positive and negative affect: the PANAS scales

10.1037/0022-3514.54.6.1063 · 1988 · External reference

Medication adherence measures: an overview

10.1155/2015/217047 · 2015 · External reference

CHAMP delivers accurate taxonomic profiles of the prokaryotes, eukaryotes, and bacteriophages in the human microbiome

10.3389/fmicb.2024.1425489 · 2024 · External reference

MaAsLin 3: refining and extending generalized multivariable linear models for meta-omic association discovery

10.1101/2024.12.13.628459 · 2024 · External reference

Polyphenol-rich beverage consumption affecting parameters of the lipid metabolism in healthy subjects

10.3390/ijms24010841 · 2023 · External reference

Unlocking the mysteries of VLDL: exploring its production, intracellular trafficking, and metabolism as therapeutic targets

10.1186/s12944-023-01993-y · 2024 · External reference

Diets naturally rich in polyphenols improve fasting and postprandial dyslipidemia and reduce oxidative stress: a randomized controlled trial

10.3945/ajcn.113.073445 · 2014 · External reference

Intake of saturated and trans unsaturated fatty acids and risk of all cause mortality, cardiovascular disease, and type 2 diabetes: systematic review and meta-analysis of observational studies

10.1136/bmj.h3978 · 2015 · External reference

Trans fatty acids and cardiovascular disease

10.1056/nejmra054035 · 2006 · External reference

The potential and action mechanism of polyphenols in the treatment of liver diseases

10.1155/2018/8394818 · 2018 · External reference

Effects of structural characteristics of phenolic compounds on oxidation of glycerol trioleate: action rule and mechanism

10.1016/j.foodchem.2023.137361 · 2024 · External reference

Inhibitory activity of natural occurring antioxidants on Thiyl radical-induced trans-arachidonic acid formation

10.1021/jf1036307 · 2011 · External reference

Discordance between very Low-density lipoprotein cholesterol and Low-density lipoprotein cholesterol increases cardiovascular disease risk in a geographically defined cohort

10.1161/jaha.123.031878 · 2024 · External reference

Effects of olive leaf polyphenols on blood lipid profiles and cardiovascular risk markers in healthy and at-risk populations: a narrative review

10.1039/d5fo04678e · 2026 · External reference

Glycerol and glycerol-3-phosphate: multifaceted metabolites in metabolism, cancer, and other diseases

10.1210/endrev/bnaf033 · 2025 · External reference

Human faecal microbiota display variable patterns of glycerol metabolism

10.1111/j.1574-6941.2010.00974.x · 2010 · External reference

The pyruvate dehydrogenase complex: life's essential, vulnerable and druggable energy homeostat

10.1016/j.mito.2023.02.007 · 2023 · External reference

Effects of the l-tyrosine-derived bacterial metabolite p-cresol on colonic and peripheral cells

10.1007/s00726-021-03064-x · 2022 · External reference

Metabolism, protein binding, and renal clearance of microbiota-derived p-cresol in patients with CKD

10.2215/cjn.00160116 · 2016 · External reference

Epigallocatechin-3-Gallate decreases plasma and urinary levels of p-cresol by modulating gut microbiota in mice

10.1021/acsomega.2c04731 · 2022 · External reference

3,5-Dihydroxybenzoic acid as a potent inhibitor of tyrosine phenol-Lyase decreases fecal phenol levels in mice

10.1021/acs.jmedchem.5c00418 · 2025 · External reference

Measuring bias in self-reported data

10.1504/ijbhr.2011.043414 · 2011 · External reference

Optimal design of clinical trials of dietary interventions in disorders of gut-brain interaction

10.14309/ajg.0000000000001732 · 2022 · External reference

Robust workflow for multiclass host-gut microbial cometabolite quantitation in human stool via 3-Nitrophenylhydrazine derivatization and LC-MS/MS: a validated analytical platform for translational studies

10.1021/acs.analchem.5c05360 · 2026 · External reference

The two-period crossover design in medical research

10.7326/0003-4819-110-7-560 · 1989 · External reference

Kinetics of very-low-density lipoprotein apolipoprotein B-100 in normolipidemic subjects: pooled analysis of stable-isotope studies

10.1053/meta.2000.8621 · 2000 · External reference

Turnover of plasma total and very low density lipoprotein triglyceride in man

10.3109/00365517509087221 · 1975 · External reference

Heritability and responses to high fat diet of plasma lipidomics in a twin study

10.1038/s41598-017-03965-6 · 2017 · External reference

Reduced mass and diversity of the colonic microbiome in patients with multiple sclerosis and their improvement with ketogenic diet

10.3389/fmicb.2017.01141 · 2017 · External reference

Polyphenols nonmonotonically modulate the inulin-driven gut microbial network in vivo

10.1021/acs.jafc.5c13003 · 2026 · External reference